Form 4: Insider Sells Disc Medicine Shares in Secondary Offering

A 10% owner and director entity sold over 744,000 shares of Disc Medicine common stock in a secondary offering.

Summary

• AI DMI LLC, identified as a 10% owner and director entity of Disc Medicine, Inc. (IRON), sold 744,047 shares of common stock.
• The transaction occurred on October 22, 2025, at a price of $80.47 per share.
• The sale was executed pursuant to an underwritten secondary offering.
• Following this transaction, AI DMI LLC directly holds 2,814,379 shares of Disc Medicine common stock.
• Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik are also reporting persons due to control relationships, but each disclaims beneficial ownership of these securities except to the extent of their pecuniary interest.

Sentiment

Score: 3

Explanation: A significant sale of shares by a 10% owner and director entity, AI DMI LLC, could be perceived negatively by the market, potentially indicating a lack of confidence or a strategic portfolio adjustment.

Negatives

• A significant sale of 744,047 shares by a 10% owner and director entity could be perceived negatively by the market, potentially signaling a lack of confidence or a move to diversify holdings.

Risks

• Potential negative market reaction to a large insider sale, which could put downward pressure on the stock price.
• Reduced insider ownership percentage, which might be viewed as a decrease in alignment between large shareholders and common shareholders.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Management Comments

• Each of the reporting persons (other than AI DMI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Industry Context

This Form 4 filing reports a specific insider transaction and does not provide broader industry context. Large secondary offerings by existing shareholders can occur for various reasons, including portfolio rebalancing or liquidity needs, and are common across industries.

Related Party Transactions

• AI DMI LLC, a 10% owner and director entity, sold 744,047 shares of Disc Medicine, Inc. common stock.
• Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik are identified as related reporting persons due to control relationships with AI DMI LLC.

Stakeholder Impact

• Shareholders: May react negatively to the insider sale, potentially leading to downward pressure on the stock price.
• Company: The company itself does not receive proceeds from this secondary offering, but the market's perception of the sale could affect its stock valuation.

Key Dates

Recommendation

The sale of a substantial block of shares by a 10% owner and director entity is a notable event that could signal a lack of confidence or a strategic portfolio rebalancing. While it's a negative indicator, without additional information on the company's fundamentals, future prospects, or the specific reasons behind the sale, a 'hold' recommendation is prudent. Investors should monitor future insider activity and company performance closely.

Keywords

Disc Medicine, IRON, SEC Form 4, Insider Sale, Secondary Offering, AI DMI LLC, Len Blavatnik, Stock Transaction, Beneficial Ownership